Subscribe
Subscribe
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.

Microbiome regulations from an EU start-up’s perspective

The Benefit of BioVox – why science journalism matters

AI and The Black Box Dilemma

Ghent knowledge hub growing strong

Mithra Women’s Health presenting good news at CPHI conference

11 October 2018 - Mithra (Euronext Brussels: MITRA), a Liège-based company dedicated to Women’s Health, provided an update on its key programmes at the CPHI world conference held yesterday. News was very positive, with the company reporting strong clinical and financial results.

What’s next for CRISPR crops in the EU?

The Nobel Assembly at Karolinska Institutet awards the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo

1st October 2018 Cancer kills millions of people every year and is one of humanity’s greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor cells this year’s Nobel Laureates have established an entirely new principle for cancer therapy.

Ghent University starts search for 21 top professors

7th September 2018 During the next few years, the faculties at Ghent University will more closely collaborate with each other in the realisation of ten interdisciplinary projects of major social impact. Ghent University is creating 21 new professorships which they will begin to fill as of this autumn.

Are the days of journal paywalls finally numbered?

Argenx raised over $300 million in their US public offering

Argenx announces launch of proposed public offering in the United States

Hot on the tail of Galapagos' successful public offering, Gent-based biotech Argenx is following suit! The biotech company, which is developing antibody-based therapies for cancer and autoimmune diseases, is offering $300 millions ADSs. This is the same amount offered by Galapagos, just last week. Belgian biotech is on a roll! All we can ask is; who's next?

Good News for Galapagos

Can weeds be programmed to exterminate themselves?

How CRISPR/Cas9 is improving drug development using zebrafish

The world’s smallest diamonds

Researchers at Hasselt University have just synthesised the world’s smallest diamonds. The gems, based on a 26-atom carbon core, will be useful in a whole range of industrial and medical applications including being used to improve MRI scans. BioVox spoke to Prof. Milos Nesladek, the mastermind behind these tiny gemstones.